Pages
Circadian research reveals promising combination therapy in preventing liver cancer at McGovern Medical School
Recent research from the lab of Kristin Eckel-Mahan, PhD, associate professor in the Institute of Molecular Medicine’s Center for Metabolic and Degenerative Diseases, reveals how a standard therapy for hepatocellular carcinoma (HCC) combined with a natural molecule called nobiletin can…
The National Institutes of Health awarded a five-year, $5.9 million P30 grant to a collaborative team of investigators, including Kristin Eckel-Mahan, PhD, associate professor in the Center for Metabolic and Degenerative Diseases, to establish the Houston Nutrition Obesity Research Center…
McGovern Medical School received $3.5 million in UT System STARs funding during FY24 in support of 11 faculty members. Established in 2004, the UT System STARs (Science and Technology Acquisition and Retention) program provides funding to help purchase state-of-the-art research…